Diabetes mellitus is not associated with worse short term outcome in patients older than 65 years old post-liver transplantation

Table 1 Baseline characteristics of the studied sample

Variables		All, n = 148	DM, n = 98	No DM, n = 50	P value
Age (years)1		68.5 ± 3.3	68.4 ± 3.1	68.5 ± 3.9	0.578
Gender (Male)2		100 (67.6%)	69 (70.4%)	31 (62.0%)	0.301
Living Donor2		115 (77.7%)	79 (80.6%)	37 (74.0%)	0.355
Cause of liver disease2	HCV	52 (35.1%)	32 (32.7%)	20 (40%)	0.341
	HBV	24 (16.2%)	14 (14.3%)	10 (20%)
	NASH	51 (34.5%)	35 (35.7%)	16 (32%)
	Others	21 (14.2%)	17 (17.3%)	4 (8%)
HCC2		58 (39.2%)	40 (40.8%)	18 (36.0%)	0.570
MELD2		22 (6-39)	22 (6-39)	21 (8-35)	0.833
BMI1 (kg/m2)		26.7 ± 5.1	26.2 ± 4.6	28.6 ± 6.1	0.048a
HTN2		52 (35.1%)	42 (42.9%)	10 (20.0%)	0.006a
Hyperlipidemia2		10 (6.8%)	9 (9.2%)	1 (2.0%)	0.100
CAD2		4 (2.7%)	3 (3.1%)	1 (2.0%)	0.692
CKD2		40 (26.4%)	28 (28.6%)	12 (24.0%)	0.554
On insulin2		60 (41.2%)	60 (60.2%)	0
On OHA2		46 (31.1%)	46 (46.9%)	0
HbA1c1		5.9 ± 1.7	6.5 ± 1.7	4.6 ± 0.8	0.000a
Length of stay (days)3		24 (2-275)	23 (2-275)	22 (4-149)	0.717

^aP < 0.05.

¹Results in mean ± SD.

²Results in counts (percentage).

³Results in median (range).

DM: Diabetes mellitus; BMI: Body mass index; CKD: Chronic kidney disease; HbA1c: Hemoglobin A1c; CAD: Coronary arterial disease; HBV: Hepatitis B; HCC: Hepatocellular carcinoma; HCV: Hepatitis C; HTN: Hypertension; MELD: Model for end-stage liver disease; NASH: Non-alcoholic steatohepatitis; OHA: Oral hypoglycemic agent.